247 related articles for article (PubMed ID: 15834613)
1. Adeno-associated virus vectors are able to restore fatty aldehyde dehydrogenase-deficiency. Implications for gene therapy in Sjogren-Larsson syndrome.
Haug S; Braun-Falco M
Arch Dermatol Res; 2005 Jun; 296(12):568-72. PubMed ID: 15834613
[TBL] [Abstract][Full Text] [Related]
2. Restoration of fatty aldehyde dehydrogenase deficiency in Sjögren-Larsson syndrome.
Haug S; Braun-Falco M
Gene Ther; 2006 Jul; 13(13):1021-6. PubMed ID: 16525484
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
[TBL] [Abstract][Full Text] [Related]
4. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.
Rizzo WB; Craft DA
J Clin Invest; 1991 Nov; 88(5):1643-8. PubMed ID: 1939650
[TBL] [Abstract][Full Text] [Related]
5. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
[TBL] [Abstract][Full Text] [Related]
6. Sjögren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2).
Rizzo WB; Carney G
Hum Mutat; 2005 Jul; 26(1):1-10. PubMed ID: 15931689
[TBL] [Abstract][Full Text] [Related]
7. Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.
Rizzo WB
Mol Genet Metab; 2007 Jan; 90(1):1-9. PubMed ID: 16996289
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome.
Sillén A; Anton-Lamprecht I; Braun-Quentin C; Kraus CS; Sayli BS; Ayuso C; Jagell S; Küster W; Wadelius C
Hum Mutat; 1998; 12(6):377-84. PubMed ID: 9829906
[TBL] [Abstract][Full Text] [Related]
9. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
[TBL] [Abstract][Full Text] [Related]
10. Sjögren-Larsson syndrome.
Rizzo WB
Semin Dermatol; 1993 Sep; 12(3):210-8. PubMed ID: 8217559
[TBL] [Abstract][Full Text] [Related]
11. RNA-based mutation screening in German families with Sjögren-Larsson syndrome.
Kraus C; Braun-Quentin C; Ballhausen WG; Pfeiffer RA
Eur J Hum Genet; 2000 Apr; 8(4):299-306. PubMed ID: 10854114
[TBL] [Abstract][Full Text] [Related]
12. Sjögren-Larsson syndrome: seven novel mutations in the fatty aldehyde dehydrogenase gene ALDH3A2.
Carney G; Wei S; Rizzo WB
Hum Mutat; 2004 Aug; 24(2):186. PubMed ID: 15241804
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic diagnosis of Sjögren-Larsson syndrome using electrospray ionization mass spectrometry.
Sanders RJ; Ofman R; Dekker C; Kemp S; Wanders RJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):451-5. PubMed ID: 19124283
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization, expression, and alternate splicing of the mouse fatty aldehyde dehydrogenase gene.
Lin Z; Carney G; Rizzo WB
Mol Genet Metab; 2000 Nov; 71(3):496-505. PubMed ID: 11073717
[TBL] [Abstract][Full Text] [Related]
15. An Indian family with Sjögren-Larsson syndrome caused by a novel ALDH3A2 mutation.
Sakai K; Akiyama M; Yanagi T; Nampoothiri S; Mampilly T; Sunitha V; Shimizu H
Int J Dermatol; 2010 Sep; 49(9):1031-3. PubMed ID: 20883264
[TBL] [Abstract][Full Text] [Related]
16. Incomplete Sjögren-Larsson syndrome in two Japanese siblings.
Kawakami T; Saito R; Fujikawa Y; Kazama H; Shinomiya N; Yamaguchi K; Yamaguchi Y; Aoki T; Kobayashi T
Dermatology; 1999; 198(1):93-6. PubMed ID: 10026413
[TBL] [Abstract][Full Text] [Related]
17. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
18. Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients.
van Domburg PH; Willemsen MA; Rotteveel JJ; de Jong JG; Thijssen HO; Heerschap A; Cruysberg JR; Wanders RJ; Gabreëls FJ; Steijlen PM
Neurology; 1999 Apr; 52(7):1345-52. PubMed ID: 10227616
[TBL] [Abstract][Full Text] [Related]
19. [Sjogren-Larsson syndrome: two cases with delayed diagnosis].
Misery L; Antoine JC; Touraine R; Wanders R; Maitre S; Has C; Perrot JL; Cambazard F
Ann Med Interne (Paris); 2002 Jun; 153(4):280-2. PubMed ID: 12218895
[TBL] [Abstract][Full Text] [Related]
20. Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.
Verhoeven NM; Jakobs C; Carney G; Somers MP; Wanders RJ; Rizzo WB
FEBS Lett; 1998 Jun; 429(3):225-8. PubMed ID: 9662422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
